Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here.
Good morning. The Olympics are officially over, and while I didn’t watch much, I can’t stop thinking about Alysa Liu‘s free skate. Specifically the last minute or so, after all the big jumps are done, and she’s dancing and sliding on her knees across the ice. It’s exuberant.
How drugmakers are navigating Trump’s FDA
Historically, decisions made by the FDA about the drugs that Americans take have been largely shielded from political influence. “It was always the case: if it’s FDA, leave it alone,” one lobbyist recently told STAT’s Daniel Payne and Lizzy Lawrence. But under the Trump administration, the strategy is morphing, with an emphasis on “currying favor” with top administration officials, as another lobbyist put it.
